Alpha Growth Share Discussion Threads

[tell sid] 07/12/2020 08:47

Pfizer vaccine expected to be approved by the FDA for use in the US this week.

[jambam] 04/12/2020 14:49

need to give Gobind a call or email. He's very helpful once you have got hold of him....everything on track...:)))

[7rademark] 04/12/2020 14:46

Again it can't hold 2p, whilst most stocks are experiencing a rapid recovery algw can't, we need to start asking ourselves just what are the BOD doing other than sfa

[lpr4850] 03/12/2020 10:03

I would also guess that the vaccine would be available privately. Might be tax deductible :-)

[city chappy] 03/12/2020 09:19

hTTps://www.proactiveinvestors.co.uk/companies/news/924479/alpha-growth-shines-as-a-specialist-in-longevity-investing-with-high-returns-on-its-blackoak-alpha-growth-fund-924479.html

[city chappy] 03/12/2020 08:13

Even just vaccinating hospital staff, carers and the elderly, in the first wave of vaccinations, will help to build useful herd immunity and reduce the R Rate, which will drop further as more age groups are vaccinated.

[tell sid] 03/12/2020 08:02

Vaccination will change the travel policy of ALGW's counter parties, enabling conclusion of the revolving credit facility. Expect this to rocket.

[7rademark] 02/12/2020 13:30

Order being filled at 2.10, so obvious but the sellers just can't help themselves.

[7rademark] 02/12/2020 12:34

Hope so it's been emotional

[jambam] 02/12/2020 12:25

nice :) let's hope that is the last we see of under 2p

[7rademark] 02/12/2020 10:39

Also if your an mm and won't sell why set the spread so tight, it's never been like this before from memory.

[7rademark] 02/12/2020 10:37

Probable, they took stock yesterday but won't sell it today for a higher price without dealing at best.

[jambam] 02/12/2020 10:20

put money on another TR1 this week

[7rademark] 02/12/2020 10:16

Something going on here, they won't move the ask up and NT online to buy.

[tell sid] 02/12/2020 09:20

And that makes ALGW a 30+ bagger from here.

[tell sid] 02/12/2020 09:19

I would rather have the Pfizer vaccine which is 95% effective and tested in over 40,000 volunteers, than Covid 19. So would most rational people. Soon there will be three vaccines approved and rolling out, and probably 10 vaccines in H1 2020.All that matters is that vaccination will change the travel policy of ALGW counter parties, enabling conclusion of the revolving credit facility.

[jambam] 02/12/2020 09:15

Some recent press:

MPG sees several key drivers of growth in the US’ life settlement market, including:

Investors are seeking above-average returns in the current low interest rate environment

The regulatory environment governing life settlements is established now and new legislation continues to support market growth. Several states are making it compulsory for insurers to inform policyholders wishing to lapse their policies that there are more lucrative opportunities to settle instead, for example

An increasing number of baby boomers are seeking ways to pay for retirement or care. The US Census Bureau predicts a 37% increase in those aged 65 years and older to 78m by 2035, for example

Retirees relying on income from savings have been badly affected by low interest rates that have depleted income and caused erosion of capital.

The increase in unemployment and negative impact on retirement funds caused by the COVID pandemic will spur more policyholders to sell their policies

[mick sturbs] 02/12/2020 09:10

Can we stick to algw discussion please.

[bad gateway] 02/12/2020 09:04

No it hasn't tewkes. End of.

“Explicitly experimental”

Dr. Michael Yeadon replied in a recent public social media comment to a colleague in the UK, “All vaccines against the SARS-COV-2 virus are by definition novel. No candidate vaccine has been… in development for more than a few months.” Yeadon then went on to declare, “If any such vaccine is approved for use under any circumstances that are not EXPLICITLY experimental, I believe that recipients are being misled to a criminal extent. This is because there are precisely zero human volunteers for…whom there could possibly be more than a few months past-dose safety information.”

Yeadon is well qualified to make the critique. As he notes in the comment, “I have a degree in Biochemistry & Toxicology & a research based PhD in pharmacology. I have spent 32 years working in pharmaceutical R&D, mostly in new medicines for disorders of lung & skin. I was a VP at Pfizer & CEO…. of a biotech I founded (Ziarco – acquired by Novartis). I’m knowledgeable about new medicine R&D.” He was formerly with Pfizer at a very senior level.

[bad gateway] 02/12/2020 08:46

Thats a very good question.

re pfizer/gates vaccine agree it will be good to get the economy up and running again but don't be the first to volunteer to test it imho..


What’s Not Being Said About Pfizer Coronavirus Vaccine

[jambam] 02/12/2020 08:35

don't quite understand why they can't conclude deals remotely? Surely they know how to use zoom etc..

[tell sid] 02/12/2020 08:10

UK approves Pfizer vaccine. Mass vaccination to begin next week. This will make it easier for UK counter parties to travel to ALGW offices. Expect Europe and US vaccination approval to follow.hTTps://www.mirror.co.uk/science/breaking-coronavirus-vaccine-pfizers-jab-23101446hTTps://www.bbc.co.uk/news/amp/health-55145696

[jambam] 01/12/2020 15:58

The life settlement market is set to continue its five-year boom in 2021 as investors seek alternatives to fully priced bonds and volatile equities, according to Managing Partners Group (MPG), the international asset management group. Life settlements are US-issued life insurance policies that have been sold by the original owner at a discount to their future maturity value and are institutionally traded through a highly regulated secondary market.

The asset class is seeing increasing interest from institutional investors and wealth managers in the US, Europe – especially Switzerland – and Asia, says MPG, which estimates that the face value of new policies coming onto the market is set to increase by 10% in 2020 to $4.6bn and this will rise to $5bn in the New Year